---
document_datetime: 2025-12-29 13:32:07
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/prepandrix.html
document_name: prepandrix.html
version: success
processing_time: 0.1140096
conversion_datetime: 2025-12-30 02:35:08.285068
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Prepandrix

[RSS](/en/individual-human-medicine.xml/66651)

##### Withdrawn

This medicine's authorisation has been withdrawn

prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Prepandrix](#more-information-on-prepandrix-1384)
- [More information on Prepandrix](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 17 December 2020, the European Commission withdrew the marketing authorisation for Prepandrix (prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, GlaxoSmithkline Biologicals SA, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Prepandrix was granted marketing authorisation in the EU on 14 May 2008 for active immunisation against H5N1 subtype of influenza A virus. The marketing authorisation was initially valid for a 5-year period. It was subsequently renewed for an additional 5-year period in 2013. It was then granted unlimited validity in 2017. The product had not been manufactured since 2010.

The European Public Assessment Report (EPAR) for Prepandrix is updated to indicate that the marketing authorisation is no longer valid.

Prepandrix : EPAR - Summary for the public

English (EN) (655.18 KB - PDF)

**First published:** 17/08/2009

**Last updated:** 21/05/2013

[View](/en/documents/overview/prepandrix-epar-summary-public_en.pdf)

[Other languages (20)](#file-language-dropdown-433)

български (BG) (776.12 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/bg/documents/overview/prepandrix-epar-summary-public_bg.pdf)

español (ES) (655.14 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/es/documents/overview/prepandrix-epar-summary-public_es.pdf)

čeština (CS) (735.51 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/cs/documents/overview/prepandrix-epar-summary-public_cs.pdf)

Deutsch (DE) (680.17 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/de/documents/overview/prepandrix-epar-summary-public_de.pdf)

eesti keel (ET) (653.25 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/et/documents/overview/prepandrix-epar-summary-public_et.pdf)

ελληνικά (EL) (782.77 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/el/documents/overview/prepandrix-epar-summary-public_el.pdf)

français (FR) (682.1 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/fr/documents/overview/prepandrix-epar-summary-public_fr.pdf)

italiano (IT) (654.6 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/it/documents/overview/prepandrix-epar-summary-public_it.pdf)

latviešu valoda (LV) (750.57 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/lv/documents/overview/prepandrix-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (705.98 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/lt/documents/overview/prepandrix-epar-summary-public_lt.pdf)

magyar (HU) (753.62 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/hu/documents/overview/prepandrix-epar-summary-public_hu.pdf)

Malti (MT) (759.76 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/mt/documents/overview/prepandrix-epar-summary-public_mt.pdf)

Nederlands (NL) (677.38 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/nl/documents/overview/prepandrix-epar-summary-public_nl.pdf)

polski (PL) (753.77 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/pl/documents/overview/prepandrix-epar-summary-public_pl.pdf)

português (PT) (655.51 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/pt/documents/overview/prepandrix-epar-summary-public_pt.pdf)

română (RO) (705.46 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/ro/documents/overview/prepandrix-epar-summary-public_ro.pdf)

slovenčina (SK) (760.78 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/sk/documents/overview/prepandrix-epar-summary-public_sk.pdf)

slovenščina (SL) (744.7 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/sl/documents/overview/prepandrix-epar-summary-public_sl.pdf)

Suomi (FI) (655.55 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/fi/documents/overview/prepandrix-epar-summary-public_fi.pdf)

svenska (SV) (677.15 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

21/05/2013

[View](/sv/documents/overview/prepandrix-epar-summary-public_sv.pdf)

## Product information

Prepandrix : EPAR - Product Information

English (EN) (1.01 MB - PDF)

**First published:** 21/12/2009

**Last updated:** 26/07/2019

[View](/en/documents/product-information/prepandrix-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-345)

български (BG) (2.84 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/bg/documents/product-information/prepandrix-epar-product-information_bg.pdf)

español (ES) (1.81 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/es/documents/product-information/prepandrix-epar-product-information_es.pdf)

čeština (CS) (2.53 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/cs/documents/product-information/prepandrix-epar-product-information_cs.pdf)

dansk (DA) (1.85 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/da/documents/product-information/prepandrix-epar-product-information_da.pdf)

Deutsch (DE) (1.85 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/de/documents/product-information/prepandrix-epar-product-information_de.pdf)

eesti keel (ET) (1.79 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/et/documents/product-information/prepandrix-epar-product-information_et.pdf)

ελληνικά (EL) (2.91 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/el/documents/product-information/prepandrix-epar-product-information_el.pdf)

français (FR) (1.85 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/fr/documents/product-information/prepandrix-epar-product-information_fr.pdf)

hrvatski (HR) (1.87 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/hr/documents/product-information/prepandrix-epar-product-information_hr.pdf)

íslenska (IS) (1.82 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/is/documents/product-information/prepandrix-epar-product-information_is.pdf)

italiano (IT) (1.84 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/it/documents/product-information/prepandrix-epar-product-information_it.pdf)

latviešu valoda (LV) (2.6 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/lv/documents/product-information/prepandrix-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.94 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/lt/documents/product-information/prepandrix-epar-product-information_lt.pdf)

magyar (HU) (2.51 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/hu/documents/product-information/prepandrix-epar-product-information_hu.pdf)

Malti (MT) (2.61 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/mt/documents/product-information/prepandrix-epar-product-information_mt.pdf)

Nederlands (NL) (1.82 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/nl/documents/product-information/prepandrix-epar-product-information_nl.pdf)

norsk (NO) (1.8 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/no/documents/product-information/prepandrix-epar-product-information_no.pdf)

polski (PL) (2.56 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/pl/documents/product-information/prepandrix-epar-product-information_pl.pdf)

português (PT) (1.85 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/pt/documents/product-information/prepandrix-epar-product-information_pt.pdf)

română (RO) (1.97 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/ro/documents/product-information/prepandrix-epar-product-information_ro.pdf)

slovenčina (SK) (2.56 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/sk/documents/product-information/prepandrix-epar-product-information_sk.pdf)

slovenščina (SL) (2.48 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/sl/documents/product-information/prepandrix-epar-product-information_sl.pdf)

Suomi (FI) (1.85 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/fi/documents/product-information/prepandrix-epar-product-information_fi.pdf)

svenska (SV) (1.81 MB - PDF)

**First published:**

21/12/2009

**Last updated:**

26/07/2019

[View](/sv/documents/product-information/prepandrix-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IB/0077 20/09/2018

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Prepandrix : EPAR - All Authorised presentations

English (EN) (599.2 KB - PDF)

**First published:** 17/08/2009

**Last updated:** 17/08/2009

[View](/en/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-55)

български (BG) (706.57 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/bg/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_bg.pdf)

español (ES) (599.09 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/es/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_es.pdf)

čeština (CS) (688.89 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/cs/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (636.44 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/da/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (599.05 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/de/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (599.16 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/et/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (692.08 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/el/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_el.pdf)

français (FR) (635.45 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/fr/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (731.49 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/hr/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (683.46 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/is/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_is.pdf)

italiano (IT) (633.94 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/it/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (688.77 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/lv/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (667.71 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/lt/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (685.93 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/hu/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (691.47 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/mt/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (598.72 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/nl/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (682.3 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/no/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_no.pdf)

polski (PL) (687.41 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/pl/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_pl.pdf)

português (PT) (635.96 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/pt/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_pt.pdf)

română (RO) (671.36 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/ro/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (686.86 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/sk/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (614.22 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/sl/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (594.07 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/fi/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (599.04 KB - PDF)

**First published:**

17/08/2009

**Last updated:**

17/08/2009

[View](/sv/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Prepandrix Active substance A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2) International non-proprietary name (INN) or common name prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) Therapeutic area (MeSH)

- Influenza, Human
- Immunization
- Disease Outbreaks

Anatomical therapeutic chemical (ATC) code J07BB02

### Pharmacotherapeutic group

Vaccines

### Therapeutic indication

Active immunisation against H5N1 subtype of influenza-A virus.

This indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared with H5N1 subtype strains.

Prepandrix should be used in accordance with official guidance.

## Authorisation details

EMA product number EMEA/H/C/000822

Accelerated assessment

This medicine had an accelerated assessment. This means that it is a medicine of major interest for public health, so its timeframe for review was 150 evaluation days rather than 210. For more information, see [Accelerated assessment](/node/69621) .

Marketing authorisation holder

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut, 89

Marketing authorisation issued 14/05/2008 Withdrawal of marketing authorisation 17/12/2020 Revision 13

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Prepandrix : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (1019.77 KB - PDF)

**First published:** 21/12/2009

**Last updated:** 26/07/2019

[View](/en/documents/procedural-steps-after/prepandrix-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Prepandrix-H-C-822-P46-0054 : EPAR - Assessment Report

Adopted

Reference Number: EMA/121454/2015

English (EN) (1.83 MB - PDF)

**First published:** 19/02/2015

**Last updated:** 19/02/2015

[View](/en/documents/variation-report/prepandrix-h-c-822-p46-0054-epar-assessment-report_en.pdf)

Prepandrix-H-C-822-P46-0055 : EPAR - Assessment Report

Adopted

Reference Number: EMA/544203/2014

English (EN) (997.23 KB - PDF)

**First published:** 29/09/2014

**Last updated:** 29/09/2014

[View](/en/documents/variation-report/prepandrix-h-c-822-p46-0055-epar-assessment-report_en.pdf)

Prepandrix-H-C-822-PSUV-0049 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation

Reference Number: EMA/252828/2014

English (EN) (636.26 KB - PDF)

**First published:** 12/05/2014

**Last updated:** 12/05/2014

[View](/en/documents/scientific-conclusion/prepandrix-h-c-822-psuv-0049-epar-scientific-conclusions-and-grounds-recommending-variation-terms-marketing-authorisation_en.pdf)

Prepandrix-H-C-822-II-0029 : EPAR - Assessment Report - Variation

Adopted

English (EN) (1.09 MB - PDF)

**First published:** 22/12/2011

**Last updated:** 22/12/2011

[View](/en/documents/variation-report/prepandrix-h-c-822-ii-0029-epar-assessment-report-variation_en.pdf)

Prepandrix-H-C-822-II-0026 : EPAR - Assessment Report - Variation

Adopted

English (EN) (1.31 MB - PDF)

**First published:** 22/12/2011

**Last updated:** 22/12/2011

[View](/en/documents/variation-report/prepandrix-h-c-822-ii-0026-epar-assessment-report-variation_en.pdf)

Prepandrix-H-C-822-II-0005 : EPAR - Assessment Report - Variation

Reference Number: EMEA/CHMP/352133/2009

English (EN) (1.01 MB - PDF)

**First published:** 17/08/2009

**Last updated:** 17/08/2009

[View](/en/documents/variation-report/prepandrix-h-c-822-ii-0005-epar-assessment-report-variation_en.pdf)

CHMP post-authorisation summary of positive opinion for Prepandrix

Adopted

Reference Number: EMEA/CHMP/62736/2008

English (EN) (32.48 KB - PDF)

**First published:** 21/02/2008

**Last updated:** 21/02/2008

[View](/en/documents/smop/chmp-post-authorisation-summary-positive-opinion-prepandrix_en.pdf)

## Initial marketing authorisation documents

CHMP summary of positive opinion for Prepandrix

Reference Number: EMEA/CHMP/334055/2009

English (EN) (766.62 KB - PDF)

**First published:** 29/05/2009

**Last updated:** 29/05/2009

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-prepandrix_en.pdf)

Prepandrix : EPAR - Public assessment report

English (EN) (969.71 KB - PDF)

**First published:** 03/06/2008

**Last updated:** 03/06/2008

[View](/en/documents/assessment-report/prepandrix-epar-public-assessment-report_en.pdf)

#### More information on Prepandrix

Public statement on Prepandrix: Withdrawal of the marketing authorisation in the European Union

Reference Number: EMEA/H/C/000822

English (EN) (123.41 KB - PDF)

**First published:** 23/02/2021

[View](/en/documents/public-statement/public-statement-prepandrix-withdrawal-marketing-authorisation-european-union_en.pdf)

#### More information on Prepandrix

- [EMEA-000160-PIP01-07-M05 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000160-pip01-07-m05)

**This page was last updated on** 23/02/2021

## Share this page

[Back to top](#main-content)